nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—FPGS—Metabolism of folate and pterines—MTHFR—cervical cancer	0.0789	0.276	CbGpPWpGaD
Raltitrexed—FPGS—decidua—cervical cancer	0.0476	0.109	CbGeAlD
Raltitrexed—FPGS—endometrium—cervical cancer	0.0452	0.103	CbGeAlD
Raltitrexed—FPGS—mammalian vulva—cervical cancer	0.0437	0.0997	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0399	0.139	CbGpPWpGaD
Raltitrexed—FPGS—female reproductive system—cervical cancer	0.0375	0.0854	CbGeAlD
Raltitrexed—FPGS—female gonad—cervical cancer	0.0341	0.0777	CbGeAlD
Raltitrexed—FPGS—vagina—cervical cancer	0.0339	0.0772	CbGeAlD
Raltitrexed—TYMS—uterine cervix—cervical cancer	0.0328	0.0748	CbGeAlD
Raltitrexed—TYMS—endometrium—cervical cancer	0.0297	0.0676	CbGeAlD
Raltitrexed—TYMS—mammalian vulva—cervical cancer	0.0287	0.0654	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0279	0.0976	CbGpPWpGaD
Raltitrexed—Febrile neutropenia—Topotecan—cervical cancer	0.0266	0.115	CcSEcCtD
Raltitrexed—TYMS—female reproductive system—cervical cancer	0.0246	0.056	CbGeAlD
Raltitrexed—TYMS—female gonad—cervical cancer	0.0224	0.051	CbGeAlD
Raltitrexed—TYMS—vagina—cervical cancer	0.0222	0.0507	CbGeAlD
Raltitrexed—FPGS—lymph node—cervical cancer	0.0219	0.05	CbGeAlD
Raltitrexed—Extravasation—Topotecan—cervical cancer	0.0184	0.0792	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—YY1—cervical cancer	0.018	0.063	CbGpPWpGaD
Raltitrexed—Tetrahydrofolic acid—MTHFR—cervical cancer	0.0164	0.373	CrCbGaD
Raltitrexed—Folic Acid—MTHFR—cervical cancer	0.0164	0.373	CrCbGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0145	0.0508	CbGpPWpGaD
Raltitrexed—TYMS—lymph node—cervical cancer	0.0144	0.0328	CbGeAlD
Raltitrexed—Sepsis—Topotecan—cervical cancer	0.0139	0.06	CcSEcCtD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.0128	0.0449	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—MTHFR—cervical cancer	0.0116	0.0406	CbGpPWpGaD
Raltitrexed—Methotrexate—MTHFR—cervical cancer	0.0112	0.255	CrCbGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—cervical cancer	0.0106	0.037	CbGpPWpGaD
Raltitrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.0104	0.0364	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0102	0.0356	CbGpPWpGaD
Raltitrexed—Neutropenia—Topotecan—cervical cancer	0.0094	0.0406	CcSEcCtD
Raltitrexed—Stomatitis—Topotecan—cervical cancer	0.00874	0.0377	CcSEcCtD
Raltitrexed—Sweating—Topotecan—cervical cancer	0.00859	0.0371	CcSEcCtD
Raltitrexed—Alopecia—Topotecan—cervical cancer	0.00711	0.0307	CcSEcCtD
Raltitrexed—Ill-defined disorder—Topotecan—cervical cancer	0.0065	0.028	CcSEcCtD
Raltitrexed—Anaemia—Topotecan—cervical cancer	0.00647	0.0279	CcSEcCtD
Raltitrexed—Malaise—Topotecan—cervical cancer	0.00632	0.0272	CcSEcCtD
Raltitrexed—Leukopenia—Topotecan—cervical cancer	0.00627	0.027	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—UBE3A—cervical cancer	0.00616	0.0215	CbGpPWpGaD
Raltitrexed—Cough—Topotecan—cervical cancer	0.00611	0.0264	CcSEcCtD
Raltitrexed—Arthralgia—Topotecan—cervical cancer	0.00596	0.0257	CcSEcCtD
Raltitrexed—Discomfort—Topotecan—cervical cancer	0.00589	0.0254	CcSEcCtD
Raltitrexed—Infection—Topotecan—cervical cancer	0.00568	0.0245	CcSEcCtD
Raltitrexed—Thrombocytopenia—Topotecan—cervical cancer	0.0056	0.0241	CcSEcCtD
Raltitrexed—Hyperhidrosis—Topotecan—cervical cancer	0.00553	0.0238	CcSEcCtD
Raltitrexed—Anorexia—Topotecan—cervical cancer	0.00545	0.0235	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00523	0.0183	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00521	0.0225	CcSEcCtD
Raltitrexed—Dyspepsia—Topotecan—cervical cancer	0.00503	0.0217	CcSEcCtD
Raltitrexed—Decreased appetite—Topotecan—cervical cancer	0.00497	0.0214	CcSEcCtD
Raltitrexed—Pain—Topotecan—cervical cancer	0.00489	0.0211	CcSEcCtD
Raltitrexed—Constipation—Topotecan—cervical cancer	0.00489	0.0211	CcSEcCtD
Raltitrexed—Feeling abnormal—Topotecan—cervical cancer	0.00471	0.0203	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Topotecan—cervical cancer	0.00467	0.0202	CcSEcCtD
Raltitrexed—Body temperature increased—Topotecan—cervical cancer	0.00452	0.0195	CcSEcCtD
Raltitrexed—Abdominal pain—Topotecan—cervical cancer	0.00452	0.0195	CcSEcCtD
Raltitrexed—Asthenia—Topotecan—cervical cancer	0.0041	0.0177	CcSEcCtD
Raltitrexed—Pruritus—Topotecan—cervical cancer	0.00404	0.0174	CcSEcCtD
Raltitrexed—FPGS—Disease—WNT2—cervical cancer	0.00397	0.0139	CbGpPWpGaD
Raltitrexed—Diarrhoea—Topotecan—cervical cancer	0.00391	0.0169	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—cervical cancer	0.00386	0.0135	CbGpPWpGaD
Raltitrexed—Vomiting—Topotecan—cervical cancer	0.00363	0.0157	CcSEcCtD
Raltitrexed—Rash—Topotecan—cervical cancer	0.0036	0.0155	CcSEcCtD
Raltitrexed—Dermatitis—Topotecan—cervical cancer	0.0036	0.0155	CcSEcCtD
Raltitrexed—Headache—Topotecan—cervical cancer	0.00358	0.0154	CcSEcCtD
Raltitrexed—Nausea—Topotecan—cervical cancer	0.0034	0.0146	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CA9—cervical cancer	0.00314	0.011	CbGpPWpGaD
Raltitrexed—FPGS—Disease—WNT5A—cervical cancer	0.00301	0.0105	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00195	0.00683	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.00178	0.00622	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HES1—cervical cancer	0.00173	0.00605	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTHFR—cervical cancer	0.00152	0.00532	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—cervical cancer	0.00152	0.0053	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.00148	0.00517	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00142	0.00498	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR3—cervical cancer	0.00139	0.00487	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NOTCH1—cervical cancer	0.00131	0.00457	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTHFR—cervical cancer	0.00127	0.00445	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA9—cervical cancer	0.00114	0.004	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.00113	0.00395	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TERT—cervical cancer	0.00108	0.00377	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTOR—cervical cancer	0.000979	0.00342	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD4—cervical cancer	0.000977	0.00342	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000947	0.00331	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—cervical cancer	0.000909	0.00318	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CTNNB1—cervical cancer	0.000868	0.00304	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT3—cervical cancer	0.000756	0.00265	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—cervical cancer	0.000687	0.0024	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—cervical cancer	0.000464	0.00162	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—cervical cancer	0.00041	0.00143	CbGpPWpGaD
